Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Obstructive sleep apnea: a comparison of black and white subjects.
Meetze K, Gillespie MB, Lee FS. Meetze K, et al. Laryngoscope. 2002 Jul;112(7 Pt 1):1271-4. doi: 10.1097/00005537-200207000-00024. Laryngoscope. 2002. PMID: 12169912
Chronic rhinosinusitis in congenital craniofacial malformations.
Woodworth BA, Meetze K, Schlosser RJ. Woodworth BA, et al. Among authors: meetze k. Int J Pediatr Otorhinolaryngol. 2006 Feb;70(2):247-52. doi: 10.1016/j.ijporl.2005.06.019. Epub 2005 Aug 8. Int J Pediatr Otorhinolaryngol. 2006. PMID: 16085320
Frontal sinus complications after frontal craniotomy.
Meetze K, Palmer JN, Schlosser RJ. Meetze K, et al. Laryngoscope. 2004 May;114(5):945-8. doi: 10.1097/00005537-200405000-00031. Laryngoscope. 2004. PMID: 15126762
Treatments for oral, pharyngeal and laryngeal carcinomas: a work in progress.
Osguthorpe JD, Meetze K. Osguthorpe JD, et al. Among authors: meetze k. J S C Med Assoc. 2003 Apr;99(4):94-7. J S C Med Assoc. 2003. PMID: 12762156 Review. No abstract available.
Profound, durable and MGMT-independent sensitivity of glioblastoma cells to cyclin-dependent kinase inhibition.
Le Rhun E, von Achenbach C, Lohmann B, Silginer M, Schneider H, Meetze K, Szabo E, Weller M. Le Rhun E, et al. Among authors: meetze k. Int J Cancer. 2019 Jul 1;145(1):242-253. doi: 10.1002/ijc.32069. Epub 2019 Jan 12. Int J Cancer. 2019. PMID: 30549269 Free article.
Novel Targeting of Transcription and Metabolism in Glioblastoma.
Su YT, Chen R, Wang H, Song H, Zhang Q, Chen LY, Lappin H, Vasconcelos G, Lita A, Maric D, Li A, Celiku O, Zhang W, Meetze K, Estok T, Larion M, Abu-Asab M, Zhuang Z, Yang C, Gilbert MR, Wu J. Su YT, et al. Among authors: meetze k. Clin Cancer Res. 2018 Mar 1;24(5):1124-1137. doi: 10.1158/1078-0432.CCR-17-2032. Epub 2017 Dec 18. Clin Cancer Res. 2018. PMID: 29254993 Free article.
Neuregulin 1 expression is a predictive biomarker for response to AV-203, an ERBB3 inhibitory antibody, in human tumor models.
Meetze K, Vincent S, Tyler S, Mazsa EK, Delpero AR, Bottega S, McIntosh D, Nicoletti R, Winston WM, Weiler S, Feng B, Gyuris J, Weng Z. Meetze K, et al. Clin Cancer Res. 2015 Mar 1;21(5):1106-14. doi: 10.1158/1078-0432.CCR-14-2407. Epub 2014 Dec 26. Clin Cancer Res. 2015. PMID: 25542901 Free article.
GP369, an FGFR2-IIIb-specific antibody, exhibits potent antitumor activity against human cancers driven by activated FGFR2 signaling.
Bai A, Meetze K, Vo NY, Kollipara S, Mazsa EK, Winston WM, Weiler S, Poling LL, Chen T, Ismail NS, Jiang J, Lerner L, Gyuris J, Weng Z. Bai A, et al. Among authors: meetze k. Cancer Res. 2010 Oct 1;70(19):7630-9. doi: 10.1158/0008-5472.CAN-10-1489. Epub 2010 Aug 13. Cancer Res. 2010. PMID: 20709759 Free article.
Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase.
Manfredi MG, Ecsedy JA, Meetze KA, Balani SK, Burenkova O, Chen W, Galvin KM, Hoar KM, Huck JJ, LeRoy PJ, Ray ET, Sells TB, Stringer B, Stroud SG, Vos TJ, Weatherhead GS, Wysong DR, Zhang M, Bolen JB, Claiborne CF. Manfredi MG, et al. Among authors: meetze ka. Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4106-11. doi: 10.1073/pnas.0608798104. Epub 2007 Feb 23. Proc Natl Acad Sci U S A. 2007. PMID: 17360485 Free PMC article.
11 results
Jump to page